| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Ball Bryan is a See Remarks at WHWK. Recent filings cover 0 purchases and 6 sales. Those positions are worth an estimated $1.8M at current prices.
Our model assigns Ball Bryan a below-average insider score of 31/100, based on 6 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -44.3%.
Ball Bryan's largest disclosed position is in WHWK as See Remarks, worth about $1.8M. The recent filings there lean toward selling, a net 179,426 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2026 | WHWK Whitehawk Therapeutics, Inc. | See Remarks | Sell | 118,849 | $3.60 | $427,860.34 | -23.0% | -4.0% | - | |
| Apr 10, 2026 | WHWK Whitehawk Therapeutics, Inc. | See Remarks | Sell | 56,596 | $3.55 | $201,124.28 | -9.9% | +13.9% | - | |
| Mar 2, 2026 | WHWK Whitehawk Therapeutics, Inc. | See Remarks | Sale+OE | 1,834 | $3.31 | $6,069.81 | -0.9% | +37.3% | - | |
| Mar 3, 2025 | WHWK Whitehawk Therapeutics, Inc. | See Remarks | Sale+OE | 2,147 | $2.35 | $5,045.45 | -2.0% | -24.3% | +44.3% |